BD Biosciences Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
Published: Apr 03, 2012
FRANKLIN LAKES, N.J., April 2, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2012 earnings conference call on Tuesday, May 1, 2012, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.
The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Tuesday, May 8, 2012.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
Monique N. Dolecki, Investor Relations 201-847-5378
Colleen T. White, Corporate Communications 201-847-5369
SOURCE BD (Becton, Dickinson and Company)